Kiniksa Pharmaceuticals
Price & Volume
Stats
See more52W Range | $16.56-$28.15 |
Market Cap | $1.6B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $423.2M |
Revenue Growth (YoY) | 46.9% |
Gross Profit (12 Mos) | $234M |
Diluted EPS | -$0.60 |
News
See moreYahoo Finance • 24 days ago
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution
Yahoo Finance • 28 days ago
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
Yahoo Finance • 7 months ago
Roth analysis: Has volatility created a trigger warning for stocks?
Yahoo Finance • last year
Investors in Kiniksa Pharmaceuticals (NASDAQ:KNSA) have seen returns of 30% over the past year
About
CEO | Mr. Sanj K. Patel |
CFO | Mr. Mark Ragosa C.F.A. |
Address | 23 Old Bond Street, London, United Kingdom, WIS 4PZ |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 315 |
